2m 2m 2m 2m 2m 2m 2m
Aurinia Pharma (AUPH)
NASDAQ
$16.17+$0.07 (+0.45%)
Price as of Sep 11, 2026 7:55 PM EDT- $2.1BMarket Cap
- 26.37%1-Year Change
- BiotechnologyIndustry
Aurinia Pharma (AUPH)
$16.17+$0.07 (+0.45%)
Earnings Score
Valuation | AUPH | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | AUPH | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -2.09% | ||
12-Month Momentum | 20.89% | ||
3-Month Risk Adjusted Momentum | -11.52% | ||
12-Month Risk Adjusted Momentum | 52.62% |
True Yield
Valuation | AUPH | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 3.83% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | AUPH | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 11 |